Published in Drug Week, August 1st, 2003
A three-judge panel declared that scientists for American Bioscience, Inc., a California company formerly known as VivoRx Pharmaceuticals, Inc., invented the analogs of the anticancer taxane class of compounds and should be named on the patent for them.
Those scientists are Chunlin Tao, Dr. Patrick Soon-Shiong and Neil Desai.
"The district court erred in its determination of inventorship," the judges ruled. "Tao,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.